NCT00119912 2026-04-14
NORCCAP
Norwegian Institute of Public Health
Phase NA Active not recruiting
Clinical Trials
19 trialsNCT01538550 2026-04-14
Pilot Study of a National Screening Programme for Bowel Cancer in Norway
Norwegian Institute of Public Health
Phase NA Active not recruiting
NCT07435025 2026-02-27
Surgery for Obstructed Gastric Carcinoma
Zagazig University
Phase NA Active not recruiting
NCT07403916 2026-02-11
Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer
P. Herzen Moscow Oncology Research Institute
Active not recruiting
NCT05177068 2025-10-02
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT07104877 2025-08-05
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
Fujian Cancer Hospital
Phase NA Active not recruiting
NCT06453590 2025-08-01
Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents
Region Stockholm
Phase NA Active not recruiting
NCT03161535 2025-07-28
Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal Cancer
Taipei Veterans General Hospital, Taiwan
Phase NA Active not recruiting
NCT06724198 2025-07-09
Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.
Sykehuset Telemark
Phase NA Active not recruiting
NCT04864067 2025-07-01
NOAHS-ARC
Servicio de Salud Metropolitano Sur Oriente
Phase 2 Active not recruiting
NCT06888531 2025-03-21
LA-ESCC
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT02867865 2025-03-13
POLCAGB
Tata Memorial Hospital
Phase 2/3 Active not recruiting
NCT02112214 2024-12-27
HELPER
National Cancer Center, Korea
Phase 3 Active not recruiting
NCT04161092 2024-10-28
SOULMATE
Vastra Gotaland Region
Phase NA Active not recruiting
NCT04891900 2024-07-08
TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
Phase NA Active not recruiting
NCT03950271 2024-02-28
SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
Phase 2 Active not recruiting
NCT01678027 2023-11-09
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
National Cancer Center, Korea
Phase 3 Active not recruiting
NCT02407119 2023-11-09
Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
National Cancer Center, Korea
Phase 3 Active not recruiting
NCT06096896 2023-10-24
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
Shandong Provincial Hospital
Active not recruiting